Carregant...
Targeting TFPI for hemophilia treatment
Hemophilia is a severe bleeding disorder treated by infusion of the missing blood coagulation protein, factor VIII or factor IX. The discovery and characterization of the anticoagulant protein tissue factor pathway inhibitor (TFPI) led to the realization that inhibition of TFPI activity could restor...
Guardat en:
| Publicat a: | Thromb Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4950664/ https://ncbi.nlm.nih.gov/pubmed/27207418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0049-3848(16)30359-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|